Trupanion (NASDAQ:TRUP) Shares Up 6.1% – Should You Buy?

Trupanion, Inc. (NASDAQ:TRUP) was up 6.1% during mid-day trading on Monday . The stock traded as high as $27.33 and last traded at $27.41. Approximately 186,882 shares changed hands during trading, a decline of 56% from the average daily volume of 423,422 shares. The stock had previously closed at $25.83.

Wall Street Analysts Forecast Growth

TRUP has been the subject of several research analyst reports. Cantor Fitzgerald lowered their price objective on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Stifel Nicolaus set a $28.00 target price on Trupanion in a research report on Friday, June 26th. Bank of America lowered their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $41.50.

Trupanion Stock Performance

The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The company’s 50 day moving average is $23.70 and its 200-day moving average is $27.63. The company has a market capitalization of $1.20 billion, a P/E ratio of 46.41 and a beta of 1.39.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping the consensus estimate of $0.07 by $0.04. The business had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. Trupanion’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.03) earnings per share. Equities analysts anticipate that Trupanion, Inc. will post 0.54 EPS for the current fiscal year.

Insider Activity

In related news, EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the sale, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This represents a 7.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO John R. Gallagher sold 3,603 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $21.69, for a total value of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares of the company’s stock, valued at approximately $717,179.85. This trade represents a 9.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 17,807 shares of company stock worth $395,482. Insiders own 5.58% of the company’s stock.

Institutional Investors Weigh In On Trupanion

A number of institutional investors have recently modified their holdings of TRUP. Kelleher Financial Advisors bought a new position in shares of Trupanion during the third quarter valued at $74,000. Kemnay Advisory Services Inc. purchased a new position in shares of Trupanion in the 4th quarter worth about $64,000. Parallel Advisors LLC boosted its stake in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 1,722 shares in the last quarter. Advisory Services Network LLC bought a new position in Trupanion in the 3rd quarter worth about $160,000. Finally, Tidal Investments LLC purchased a new stake in Trupanion during the 2nd quarter valued at about $212,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.